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ABSTRACT 
Ultraviolet-B (UV-B) irradiation of platelet concentrates (PC's) may 
prevent the development of post-transfusion human leukocyte antigen (HLA) 
alloimmunization. This study evaluated the effect of UV-B radiation on 
stored PC's. Pooled PC's were irradiated at UV-B doses of 600, 2,400 or 
10,000 mJ/cm^ and stored up to 96 hours under standard blood bank 
conditions. Compared to non-irradiated room temperature and heat (37C) 
controls, the treated units showed no significant changes in platelet 
count, white cell count, discharge of lactate dehydrogenase, release of B- 
thromboglobulin, adenosine triphosphate, adenosine diphosphate, ammonia, 
glutamine, glutamate, hypoxanthine, PCO2 or PO2 at any time of storage 
following any of the three UV-B doses. However, after a dose of 10,000 
mJ/cm^, there were significant decreases in assays of platelet function, 
specifically osmotic recovery and morphology score. Metabolic systems 
were also affected, with a decline in pH and augmented glucose consumption 
and lactate production (p<0.05). These changes only appeared following 96 
hours of post-irradiation storage, and were not seen in either control 
group. Thus, heat generated during irradiation did not affect in vitro 
platelet function. Using computer analysis of two-dimensional 
polyacrylamide gel electrophoresis patterns, PC's irradiated at 10,000 
mJ/cm^ and stored for 72 hours exhibited alterations in over 50 platelet 
proteins as compared to an age-matched non-irradiated control. It can be 
concluded that UV-B irradiation of PC's at doses up to 10,000 mJ/cm^ does 
not induce significant metabolic, functional or protein derangements 
following short-term storage (24-48 hours). It is likely, however, that 
high dose UV-B irradiation followed by long-term storage (72-96 hours), 
will adversely affect some platelet metabolic and functional properties. 
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INTRODUCTION 
The availability of platelet concentrates (PC's) for routine 
transfusion has significantly reduced the morbidity and mortality due to 
hemorrhage in the thrombocytopenic patient. Perhaps nowhere has this 
treatment modality proven to be of greater value than in the support of 
patients with thrombocytopenia due to bone marrow failure (amegakaryocytic 
thrombocytopenia). For example, patients with malignant disease who 
receive myelosuppressive chemotherapy often need repeated platelet 
transfusions either to prevent or treat bleeding associated with periods 
of profound thrombocytopenia.^ It is expected that such transfusion will 
result in an increase in the number of circulating platelets. The 
magnitude of this increase, known as the platelet increment, is of 
interest because it has been shown that there is a quantitative 
relationship between the number of circulating platelets, i.e. the 
platelet count, and the subsequent risk of clinical bleeding.^ However, 
it is found in practice that not all PC transfusions result in the 
increment that is predicted based on the number of platelets transfused. 
This implies that the donor's platelets are rapidly removed from the 
recipient's circulation. If a patient receives several transfusions and 
consistently fails to achieve the expected increment following each 
infusion, then a state of refractoriness is said to exist.^ 
The causes of platelet refractoriness are most conveniently divided 
into those with immune and those with nonimmune mechanisms. The latter 
category includes patients with hypersplenism, fever, sepsis, hemorrhage, 
consumptive coagulopathies, e.g. disseminated intravascular coagulation, 
and hepatic veno-occlusive disease.^ If all of these are excluded by 
history, physical examination and appropriate laboratory investigations, 
then an immune etiology should be considered. Several groups of platelet 
surface alloantigenic molecules, including those bearing ABO antigens and 
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platelet specific antigens have been implicated as causes of platelet 
refractoriness.^'^ However, it is generally believed that the majority of 
cases of immune refractoriness are the result of HLA sensitization, i.e. 
alloimmunization with resultant antibody production and proliferation of 
cytotoxic lymphocytes, to human leukocyte antigen (HLA) system Class I 
antigens, which are known to be present on platelets.^ Although there is 
no single test for the presence of such antibodies that offers 100% 
sensitivity and specificity,^ one study using a lymphocytotoxic (LCT) assay 
found that the presence of an LCT antibody was predictive of 
refractoriness to random donor PC transfusion in 88% of patients and the 
absence of an antibody presaged adequate increments in 77% of patients.^ 
The overall incidence of HLA alloimmunization in patients receiving 
multiple PC transfusions is unknown with estimates ranging from 30-60% 
depending upon the population studied.^ In addition, it is interesting to 
note that a clear dose-response relationship has not been found. In one 
study of patients undergoing remission induction chemotherapy for acute 
nonlymphocytic leukemia, the overall rate of alloimmunization with 
refractoriness was 38%. However, there was no correlation between the 
number of transfusions and the incidence or severity of alloimmunization.^ 
In a second study from the same group, it was found that of those patients 
who did not become HLA alloimmunized early in a long course of platelet 
transfusions, 92% never became refractory and those who became 
alloimmunized early tended to remain so.® Another study of oncology 
patients did suggest that, in some cases, HLA antibody production may be 
transient and that HLA antibody may, in a small number of patients, even 
disappear despite continued random donor PC transfusion.^ There is, 
unfortunately, no reliable way of predicting which patients will become 
sensitized or which will spontaneously lose their sensitization. What is 
known is that the thrombocytopenic patient refractory to further 
transfusions presents a difficult management problem.^ 
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One proven approach for treating HLA-alloitninunized patients involves 
the transfusion of HLA-matched PC's. The standard platelet transfusion 
consists of a pool of 6-10 individual random donor units of platelet 
concentrate (RDP’s), each prepared from the blood of a different 
individual. It is possible, however, to prepare from a single individual 
a unit of PC, which contains a number of platelets equivalent to that 
contained in a 5-6 unit pool. This is known as a single donor platelet 
(SDP) unit and is obtained using automated or manual pheresis techniques 
(See Materials and Methods). This technology, combined with HLA typing, 
allows for the provision of an HLA-matched product that will hopefully be 
compatible with the patient's immune system by not presenting any antigens 
that will be recognized as foreign. Fortunately it has been found, in 
most cases, that matching of all donor and recipient HLA Class I loci is 
not required for successful transfusion.^ Antigens at the HLA-C locus are 
not routinely typed because compatibility at this locus does not appear to 
be required to successfully transfuse an HLA alloimmunized recipient.^ 
This leaves the HLA-A and -B loci to be matched and, while it may be 
difficult to find a truly compatible donor, the results of a complete HLA- 
A and -B matched transfusion are usually excellent. One series reported 
an 80% success rate with such transfusions in alloimmunized patients. 
When the match was less compatible, the rate of successful transfusion was 
appreciably lower, dropping to about 60% for the poorest matches. 
It is clear from these studies, however, that even when an ideal 
HLA-matched product is available, and this will not always be possible for 
those patients with rare HLA types, some refractory patients will still 
not benefit. While a number of these refractory patients have non-immune 
causes, it is believed that some of these cases of refractoriness are 
immune in origin, but may involve antigens other than the routinely typed 
HLA-A and -B loci.^ For the alloimmune refractory patients unresponsive 
to the transfusion of HLA-matched PC's, and for those refractory patients 
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for whom a suitable HLA-matched donor cannot be found, there are no 
transfusion strategies available that reliably overcome immune platelet 
destruction,^ nor is there any way of predictably reversing 
alloimmunization.^^ Although a low rate of spontaneous loss of immune 
refractoriness has been noted,prevention of alloimmunization clearly 
shows the most promise for maintaining responsiveness to platelet 
transfusions in chronically transfused patients. 
One tactic seeks to prevent or delay the onset of alloimmunization 
by transfusing only SDP's. The rationale is that by minimizing the number 
of foreign antigens to which the recipient is exposed (as opposed to using 
RDP's), the time to develop alloimmunization will be delayed.^ Although, 
as noted above, a dose response relationship does not appear to govern the 
occurrence of alloimmunization when RDP's or SDP’s are used,^ at least one 
prospective, randomized study has suggested that the use of SDP's may 
delay sensitization.^^ However, another randomized, prospective study 
showed no benefit of SDP's over pooled PC's.^^ An extension of the SDP- 
only approach is the use of HLA-matched SDP's. Here, again, the concept 
is that by minimizing exposure to potentially immunizing antigens, HLA 
alloimmunization might be delayed or eliminated. A prospective, 
randomized evaluation of HLA-matched (degree of match not given) SDP's 
versus HLA-mismatched SDP's in oncology patients did show an advantage of 
the HLA-matched product in preventing alloimmunization.^^ All five of the 
patients who developed persistent anti-HLA or other anti-platelet antibody 
during the study had initially been randomized to receive mismatched 
SDP's.However, three of these five patients continued to have adequate 
increments with mismatched SDP's and the study did not demonstrate a clear 
advantage in clinical outcome for the initial use of HLA-matched versus 
HLA-mismatched products. Given the overall low rate of alloimmunization 
(18%) in this study and the relatively small number of patients enrolled 
(78), it is difficult to draw conclusions regarding the potential of HLA- 
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matched SDP's to prevent or delay alloimmunization. In any case, the 
expense and effort required to provide HLA-matched SDP's for all patients 
likely to require multiple transfusions would overwhelm already overtaxed 
blood centers and hospitals. Only the largest facilities would have 
access to a donor base of several thousand individuals which would be 
needed to provide a varied pool of HLA-typed donors.^ 
A second approach attempts to reduce the host's immune response to 
the transfused mismatched antigens. Support for this hypothesis comes 
from the observation that leukemic patients tend to develop 
alloimmunization at a lower rate than do patients with aplastic anemia.^ 
It has also been noted that oncology patients receiving chemotherapy 
exhibit a lower than expected rate of Rh sensitization following Rh- 
incompatible platelet transfusions.^^ If the difference is due even in 
part to the immune suppression associated with intensive cytotoxic 
therapy, then perhaps more selective modulation of host immunity might 
also be beneficial. An animal study using cyclosporine has demonstrated 
just such an effect. Of dogs treated with oral cyclosporine, 100% 
remained tolerant to repeated, unrelated donor, platelet transfusions.^^ 
However, the potentially serious side effects of currently available 
immunosuppressive agents preclude their routine use for alloimmunization 
prophylaxis. Also, animal studies have shown that reversal of established 
alloimmunization via immune suppression is not as easily obtained as is 
prevention of aloimmunization. ^ ^ 
A third approach seeks to reduce the immunogenicity of the 
transfused product. Studies have demonstrated that, although the 
antibodies that cause refractoriness are directed at HLA Class I antigens 
on platelets, the platelet itself is a weak immunogen. In fact, in 
animals transfused with platelet concentrates containing only platelets, 
alloimmunization to HLA antigens does not occur. This same study 
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demonstrated that only when white cells were present in the platelet 
transfusion did alloimmunization occur. Although the details of the 
process leading from PC transfusion to HLA Class I sensitization have yet 
to be fully elucidated, further investigation has revealed that a subset 
of leukocytes, those carrying HLA Class II antigens in addition to the 
Class I antigens present on all leukocytes and platelets, is responsible 
1R for the immunogenic nature of PC's. 
The white cells that carry Class II antigens are generically 
referred to as antigen-presenting cells (APC's) and, while macrophages, 
monocytes and B-lymphocytes have APC functions, it is believed that 
dendritic cells (DCs) are the primary cell type fulfilling this role in 
humans.^® As the standard blood bank methods of preparing PC's using 
differential centrifugation do not exclude white cells, significant 
numbers of so-called passenger leukocytes are present in the final 
product. This number is typically on the order of 10®-10^ per bag of PC 
prepared from a single unit of whole blood using standard centrifugation 
protocols, with less than 5% of these being DC's.^® In theory then, it 
should be possible to reduce or eliminate the immunogenicity of PC's if 
the passenger leukocyte APC's could in some way be removed or inactivated. 
Physical removal of leukocytes may be accomplished by one, or a 
combination, of means; centrifugation, cell washing or filtration. 
However, these methods are not equally effective in removing leukocytes, 
sparing platelets and preventing alloimmunization. For example, a 
randomized, prospective trial of standard PC's versus PC's that had been 
leukocyte-depleted by centrifugation failed to demonstrate a lower rate of 
alloimmunization with the leukocyte-depleted product.Moreover, while 
centrifugation resulted in the removal of about 81% of the leukocytes, 27% 
of the platelets were also lost.^^ In this study, each unit of PC 
contained approximately 10^ leukocytes, i.e. depletion by less than 1 log^Q 
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as compared to a standard unit. Prevention of alloimmunization, it was 
hypothesized, may require that a larger fraction of the contaminating 
leukocytes be removed prior to transfusion. Indeed, studies using more 
elaborate centrifugation and washing protocols to remove larger numbers of 
white cells have shown a clear benefit of leukocyte-depletion in 
preventing alloimmunization.But, in all cases, the processing 
resulted in a 20-40% loss of platelets and was cumbersome. A method that 
is both more convenient and efficient would clearly be desirable. 
Such a method exists in the form of so-called leukocyte depletion 
filters. Blood filtration technology now includes modification of cotton¬ 
wool and polyester filter surfaces with a variety of organic polymers that 
provide selective adsorption by cell type, e.g. leukocytes. These so- 
called third-generation filters offer selectivity and efficiency 
unavailable in the first- and second-generations.^^'^^ Third-generation 
filters reliably remove three logs of leukocytes (leaving about 10^ 
leukocytes per PC unit) without any substantial decrement in platelet 
quantity or any detectable deterioration in qualitySeveral large 
patient trials have consistently shown a significant reduction, by up to 
80%, in the frequency of alloimmunization when these filters are used.^®'^^ 
These filters offer the convenience of bedside use and may become the 
standard of care for the patient beginning a long series of platelet 
transfusions who is not HLA alloimmunized at entry. It should be noted 
that leukocyte removal would not be expected to reduce the incidence of 
immune refractoriness due to non-HLA sensitization, e.g. platelet-specific 
antibodies, as APC's are not believed to be involved in non-HLA 
immunization. Clinical trials have verified this prediction. 
A final approach to reducing the immunogenicity of PC's is based on 
the observation that exposure to ultraviolet (UV) radiation abolishes the 
ability of lymphocytes to stimulate allogeneic cells in a mixed lymphocyte 
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reaction (MLR).^^ As discussed above, it is believed that the presence of 
competent antigen-presenting cells (APC's) is essential for HLA 
immunization to occur.Studies using UV-A (320-400 nm) with a psoralen 
as a photosensitizing agent,UV-B (280-320 nm)^'*’^^ and UV-C (200-280 nm)^® 
have all confirmed that UV radiation impairs the ability of dendritic 
cells and other leukocytes to function as APC's. Further investigation 
has revealed that UV radiation has manifold effects and that it is likely 
that the impairment of APC function is due to a combination of factors. 
Among the reported adverse effects of UV radiation on APC's are: a direct 
reduction of cell viability via a cytocidal action (UV-B, UV-C)an 
increase in intracellular calcium concentration in resting cells with a 
failure to mobilize additional calcium when stimulated (UV-B, UV-C)a 
blockade of interleukin production, including IL-1, IL-2 and IL-6 (UV-A, 
UV-B, UV-C);^^'^^ a decrease in surface expression of intercellular adhesion 
molecule-1 (ICAM-1) (UV-B) which is thought to be important in the 
recognition of donor APC's by recipient T-lymphocytes. It has also been 
suggested that loss of HLA Class II antigens may occur following UV-B 
exposure. Other investigators, however, have not documented any 
decrement in Class II molecules. 
Given the fact that UV exposure appears to abrogate the ability of 
APC's to present antigen to lymphocytes in culture, it was suspected that 
UV-irradiated PC's might also be less likely to cause alloimmunization. 
This has been confirmed in several animal studies. In both dog and mouse 
models, the use of UV-irradiated blood products is consistently associated 
with a lower rate of HLA alloimmunization for a given number of 
transfusions. A limited (32 patients) human trial, comparing the use 
of UV-B irradiated PC's to non-irradiated units, has demonstrated a 50% 
reduction in the frequency of HLA alloimmunization.^^ One of the animal 
studies also suggested that not only does UV radiation prevent HLA 
alloimmunization, but that the transfusion of blood products containing 
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UV-irradiated leukocytes may result in a broad state of tolerance in the 
recipient.As large human trials are currently underway to evaluate the 
efficacy of UV treatment for prevention of HLA-mediated refractoriness, 
the precise implications of an induced, non-specific immune tolerance of 
this type are unknown. Conceivably, both beneficial effects, such as 
enhanced rate of allograft acceptance, and adverse effects, such as 
greater susceptibility to infections, might be seen. 
The foregoing discussion has focused on what UV radiation does to 
the passenger leukocytes. For UV irradiation to be a useful modality, 
however, it would have to be shown that the platelets themselves are not 
damaged in the process. Studies involving irradiation of human PC's have 
been reported using both UV-A and UV-B. In order for UV-A to efficiently 
abolish the APC activity of leukocytes, a psoralen must be added as a 
sensitizing agent.One group has reported that there are no clinically 
significant adverse effects of such treatment on the in vitro function of 
platelets.The parameters evaluated included pH, platelet count, lactate 
dehydrogenase leakage, morphology score, dense and alpha granule release 
and platelet aggregation studies (see Materials and Methods for 
explanation of these measurements). Because UV-B radiation is effective 
without the addition of a sensitizing agent, it has shown the most promise 
for clinical use. As there is neither standardized equipment nor accepted 
procedures, each UV-B irradiation system is different in some respects. 
Therefore, the doses of UV-B radiation reported should be taken to be 
approximations of the actual energy delivered to the leukocytes in the 
platelet concentrates. For example, a 2 mm thick plasma layer has been 
shown to allow only 0.03% transmittance of UV-B energy emitted by a common 
broad-band UV-B source.Clearly, consistent results could only be 
expected for experiments conducted with a constant thickness of PC during 
irradiation. Other variables to be considered include type of plastic, 
UV-B source and use of agitation during irradiation. Also, it would be 
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important to consider whether the effects of UV-B irradiation are seen 
immediately and if storage intensifies or attenuates any damage that is 
caused. 
One of the earliest studies reported used a UV-B dose of 
approximately 180 mJ/cm^.^^ Although the platelet concentrate was 
irradiated in 15 mL aliquots, which is too small to be useful clinically, 
no adverse effects on platelet in vitro function were found immediately 
post-irradiation as determined by a panel of aggregation studies. The UV- 
B dose was noted to have effectively abolished the ability of treated 
lymphocytes to stimulate in an MLR. However, while in vitro aggregation 
is an important measure of platelet function, it is possible that other 
assays, or a period of storage following irradiation, might have revealed 
defects. Also, the small volumes of PC irradiated meant a very thin film 
of plasma was present in the bag during irradiation. This likely allowed 
a lower dose of UV-B to be used than would be required to treat clinical 
volumes of PC. 
Pamphilon ^ al.have reported irradiation of standard blood bag 
volumes of PC at 300 mJ/cm^ followed by storage for up to 5 days — the 
maximum currently approved storage period for PC’s. This dose effectively 
blocked an MLR, but in vitro assays showed some potentially important 
differences in the irradiated versus non-irradiated units. Glucose 
consumption, lactate production, and alpha granule release were all 
greater statistically (p<0.05) in the UV-B group and some of these changes 
became more prominent with increasing time of storage following treatment. 
No statistically (p<0.05) significant changes in pH, osmotic recovery or 
aggregation were seen and one-dimensional polyacrylamide gel 
electrophoresis (PAGE) patterns were comparable. Also, in vivo autologous 
radiolabel studies gave similar results for recovery and survival. 
However, hemostatic efficacy was not assessed and the alterations in 
■fl 
' ■ t •KfV'* > ' i. 04,. 
.•*'<■ •:,.. ? «v 14 ,' • ■,HH»*.>y t li .4 
ib »io 
" Vi.. 
■ - • ‘,*11% van mt 11^ 
u .' 2‘*;^.-i '* %#®4ii!w •*•'■■■ !'♦•■ ^ '^■■■■^ 
f ••'■•<’ m9m.-m^ 9 
•j* T-. *» ‘ - 'V-^, 
■■ ■ 
■ 1 ., «■• /r, t*t0m ..*44* ». Vl4l>% 
I*') 
« /I ffj J^tOt <b4M ««nK«i<) t7> 
,-'i . • 4rt 111*- •^4<^ 4 “ 
.Jff I* 
*'45.• ' '..i ' * " 4. r ' • •.•t4.J **, J 
,n V’n-u , » *<it *4 B% bm' • • 
■ i'# m ' i »fN«'4k- ■‘‘.#5^4 ■t*^*^***l*i 
-Z I ^M»».'«Bl 4—-^*# *Oli^fb lt4 *%if •* '■• ■> 
■#• • ;i , -■> ». ’4JiC*f 4l•ii*■’■«• »4J ♦♦* 
. -t **.* ^r- «■ -;.». -.fK} ■ “'*.1 -’ J~'»I - ' . -I 
. ....'.* v*;- -.. >»14 'i' '* ‘*'‘ ■ ^ J .: . - . ■•*. c 
•? .■• :- |iv •?'*•• Tt ’»i ..r i.'Jtjk' .iv t. 
.J-3 ■ 1 ,f45:',^1* ;«*»*«;•., f, ( f.''i.<>,'j. . -'H 
i« •in.—.05* ■ ■ '‘t> i..i ■■■ ~ m> . ■ ' r.-•» ^ lif’v '-'•u* ■■*'* 
• . s-j'' » i.!** sii* .c]#riJ4r.i^ ' *• r^n-sp- 
.♦I' •■ l^r » if.}' -.il 4iff\4Mri </*■■* ■*...W,J * / iji .ftV 
i*i |H)Pt •■ ' •-* • ' ' " /"iNb ' » • > 
-11- 
glucose and lactate levels suggested that UV-B exposure may have induced 
changes in energy metabolism. To date, however, there are no published 
data regarding the specific effects of UV-B radiation on energy or 
intermediary platelet metabolism. 
Other studies have used higher doses of UV-B energy. Andreu et al 
reported no adverse effects on in vitro aggregation for doses up to 3000 
mJ/cm^; decreased aggregation responses were noted, however, for doses 
above that level. Autologous transfusion studies did consistently show a 
decreased time of survival for platelets treated with 1500 mJ/cm^, but the 
number of subjects was too small to allow meaningful statistical analysis. 
Van Prooijen ^ al. . at a dose of 6000 mJ/cm^, found significant 
decrements in aggregability, a decrease in platelet thromboxane B2 content 
and increased macroscopic clumping. However, some of the techniques used 
were not consistent with clinical blood bank practice, e.g. irradiation in 
Petri dishes. Buchholz ^ al.used a UV-B dose of 2600 mJ/cm^ and 
performed paired (same donor) transfusion studies comparing treated and 
untreated PC's. No differences were observed in in vivo survival, 
platelet count increment, or hemostatic efficacy as measured by correction 
of bleeding time. However, the increment and bleeding time studies did 
not involve storage following irradiation. The issue of post-irradiation 
storage is an important one. If UV treatment is proven in large clinical 
trials to be effective in reducing the rate of alloimmunization, then the 
ability to store an irradiated unit of PC would reduce problems with 
inventory control. This issue would arise when irradiated products go 
unused or if radiation treatment is performed at a few centers with 
distribution to outlying hospitals. 
In summary, alloimmunization to HLA Class I antigens is an important 
cause of platelet transfusion refractoriness in multiply transfused 
patients. The mechanism of this phenomenon has yet to be fully 
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elucidated. Functional donor antigen presenting cells (APC's) have, 
however, been found to be an essential link in the immunization process. 
Based on this observation, two strategies have been proposed to reduce the 
immunizing potential of PC's. The first, leukocyte depletion by 
filtration, has already been shown in large clinical trials to reduce the 
frequency of HLA alloimmunization and to have no adverse effects on 
platelets. The second, UV-B radiation, which blocks APC function, is 
currently being evaluated in patient trials. Animal studies have 
suggested that UV abolition of APC function, as measured by an MLR, may be 
a method to reduce the incidence of alloimmunization. The experiments 
detailed below were, therefore, undertaken to evaluate what effects, if 
any, UV-B treatment and subsequent storage have on in vitro platelet 
function. 
Previous published studies had evaluated some of the in vitro and in 
vivo effects of doses of UV-B radiation up to 6000 mJ/cm^. However, the 
picture was incomplete in several important respects. Doses above 6000 
mJ/cm^ with subsequent storage had yet to be studied using UV irradiation 
procedures consistent with clinical transfusion practice, e.g. standard 
blood bag volumes. Also, while it is known that UV irradiation may lead 
to significant warming of the PC, this factor had not been systematically 
evaluated in any of the published studies.In addition, there were 
several in vitro assays that had not been reported in the UV treatment 
literature. Platelet energy metabolism following UV-B treatment had been 
partially addressed by Pamphilon ^ when glucose and lactate were 
measured. But, more detailed studies of energy metabolism, e.g. PCO2, PO2, 
adenosine diphosphate (ADP) and adenosine triphosphate (ATP), had yet to 
be done. Levels of key purine and ammonia metabolites had also not been 
reported for UV-treated PC's. Finally, while one-dimensional PAGE had 
been used to examine protein changes caused by a low dose (300 mJ/cm^) of 
UV-B radiation,^® the more sensitive two-dimensional PAGE method had not 
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yet been applied. This thesis research was planned to examine these 
issues. 
MATERIALS AND METHODS 
Two sets of experiments were conducted. The first investigations, 
from June-August of 1989, involved only a single high dose (10,000 mJ/cm ) 
of UV-B radiation followed by a battery of in vitro assays. The second 
group of studies, conducted from November of 1991 to January of 1992, used 
three different doses (600, 2400 and 10,000 mJ/cm^) of UV-B to evaluate any 
dose-response phenomena and was likewise followed by a series of in vitro 
tests, including assays of intermediary metabolites. The cooperation and 
collaboration of several individuals were vital to the performance of many 
of these assays. Their specific contributions are detailed at the end of 
each section describing the materials and methods used in each set of 
experiments. 
Part A! Storage of platelet concentrates after high-dose UV-B (10,000 
mJ/cm^) irradiation 
Standard units of platelet concentrate (PC's), collected from normal 
adult volunteer donors, were purchased from the American Red Cross Blood 
Services, Connecticut Region. These PC's were prepared by centrifugal 
fractionation of CPD (citrate-phosphate-dextrose)/AS-1 (adenine-saline) 
anticoagulated whole blood units according to standard Red Cross 
procedures. 
For this study, 6 units of ABO-identical PC's (45-65 mL per unit), 
each in a 300 ml PL-732 blow-molded polyolefin bag (Baxter Healthcare 
Corporation, Fenwal Division? Deerfield, IL), were pooled aseptically into 
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a single 300 mL PL-732 bag using a plasma transfer set (#4C-2243, Baxter 
Healthcare). Under normal blood bank conditions, PC's may be stored for 
up to 5 days following collection. If the sterility of the container is 
violated, as by aseptic pooling, the shelf-life of the now open system is 
4 hours (as mandated by FDA regulations). Therefore, for patient use, 
aseptic pooling would impose unacceptable time limitations. However, 
sterile connecting devices which allow 5 day storage of pooled PC's have 
become available since the first set of experiments; such a device was 
used in the second series of experiments (Part B). Sterile, 4 unit pools 
of ABO-identical PC's have been shown to be acceptable for clinical use 
following storage by both in vitro and in vivo evaluation, including the 
absence of any mixed lymphocyte reaction (MLR).^^ The PC's were pooled 
within 24 hours of collection, following completion of required viral 
antibody/antigen testing. After thorough gentle mixing, a sample was 
taken using a self-sealing sampling-site coupler (#4C-2405, Baxter 
Healthcare) and a plastic syringe with a 19-gauge needle; this was the 
pre-irradiation sample. Next, the 6 unit pool was split into a two unit 
volume to be stored without irradiation as a control and a 4 unit volume 
to be irradiated in a 500 ml PL-269 plastic bag (Baxter Healthcare). PL- 
269 is an experimental plastic which allows approximately 58% 
transmittance of the incident UV-B radiation.PL-269 is not, however, 
approved by the United States Food and Drug Administration for PC storage. 
The polyolefin plastic used for storage, PL-732, allows no more than 14% 
transmittance of UV-B radiation^^ and is, therefore, not suitable for 
irradiation. Therefore, PC's were irradiated in PL-269 and then 
transferred to PL-732 for storage. (See Figure 1 for flow diagram of PC 
handling) 
The irradiation device used was an engineering prototype assembled 
by Baxter Healthcare for a clinical protocol (FRCP-0386) in which Yale-New 
Haven Hospital participated. It is a 12 bulb unit with 6 UV-B tubes 
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above a UV-transparent quartz glass plate and 6 tubes below. The bulbs 
(BLE-1T158, Spectronics Corp.; Westbury, NY), arranged in parallel, emit 
radiation in the wavelength band 280-320 nm. The radiation flux 
(mJ/cm^/sec) across this band was measured using a radiometer with peak 
sensitivity at 310 nm (UVX Digital Radiometer, UVP Inc.; San Gabriel, CA) . 
These data were then used to calculate the time required to deliver a 
total dose of 10,000 mJ/cm^ to the surface of the plastic bag. This time 
was calculated to be approximately 17 minutes. The 10,000 mJ/cm^ dose had 
been assigned to Yale-New Haven Hospital for patient trials by the sponsor 
(Baxter Healthcare). It should be noted that each irradiation system, 
i.e. plastic, UV radiation source, volume of plasma irradiated, agitation, 
is different,as neither equipment nor procedure has been standardized. 
For all of the experiments, a 4 unit volume of PC was irradiated in 
a 500 mL PL-269 bag to maintain a consistent plasma thickness. 
Temperature fluctuations within the irradiation chamber were minimized by 
cooling fans. However, over the time required for irradiation, the 
temperature of the PC did increase to approximately 30°C. As PC's are 
normally stored at 20-24°C, this amount of warming was not felt to be 
harmful. It was not, however, controlled for in this series of 
experiments. The PC's were not agitated during irradiation. 
After irradiation, the 4 unit test volume was split into two 2 unit 
volumes to be stored in standard 300 mL PL-732 bags with continuous gentle 
agitation provided by a 2 rpm circular rotator (Helmer Labs; St. Paul, 
MN). The control unit was also stored on the 2 rpm circular rotator. All 
PC's were kept at 22 °C in a temperature controlled cabinet (Forma 
Scientific; Marietta, OH). The control and test PC's were sampled 
immediately post-irradiation (0-4 hours) and at 24 and 96 hours post¬ 
irradiation. The 96 hour time point corresponds to 5 days post¬ 
collection, i.e. the maximum allowed storage period. 
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The pH was measured at 25°C using a standard pH meter (PHM82, 
Radiometer; Copenhagen, Denmark). PC samples were diluted 1:10 with 
normal saline for platelet counting on a laser particle counter (ELT-800, 
Ortho Diagnostics Systems; Westwood, MA). White cell counts were run on 
undiluted samples on a laser particle counter (Coulter Counter T660, 
Coulter Electronics; Hialeah, FL) . The dilution of PC samples for 
automated platelet counting was required to yield a count within the range 
where the machine provided reproducible results. White cell counts did 
not require dilution. 
Morphology score was determined using the method of Kunicki ^ al. 
This is a semi-quantitative assay of platelet integrity which consists of 
microscopic examination of unstained and unfixed samples of PC and 
assignment of a score based on counting 200 platelets with points awarded 
as follows: 4 for a disc, 2 for a sphere, 1 for a dendritic form and 0 for 
balloons or bizarre shapes. As a disc is the expected shape of a viable 
platelet, the highest possible score is, therefore, 800. 
Osmotic recovery, also known as hypotonic shock response, is an 
assay that depends on the phenomenon of transient platelet swelling in a 
hypotonic medium. It was noted by Fantl^^ that placement of platelets in 
a hypotonic medium resulted in an immediate decrease in absorbance at 610 
nm followed by a gradual increase in absorbance towards baseline. This 
has been interpreted to reflect initial platelet swelling due to free 
water influx followed by contraction with extrusion of water. The percent 
of osmotic recovery is defined as the fraction of initial absorbance 
attained in a given period of time following the addition of a hypotonic 
fluid. The procedure involves the measurement of baseline absorbance of 
a normal saline dilution of PC followed by measurement of absorbance at 10 
minutes following identical dilution with distilled water. Absorbance was 
measured by a Varian DMS 90 Spectrophotometer (Varian Techtron Ltd. ; 
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Mulgrave, Australia) at 610 nm with hardcopy tracing on a chart recorder 
(Linear Model 625, Varian Instrument Group; Sunnyvale, CA). 
The tangent of osmotic recovery was also determined. This measures 
the tangent of the angle formed by the intersection of the horizontal 
baseline and a line tangent to the tracing of the increasing absorbance at 
the point of the tracing's steepest slope, i.e. the point where the 
absorbance is increasing most rapidly. A higher tangent, therefore, 
corresponds to a more rapid osmotic recovery by the PC. This is taken to 
be additional information regarding the total metabolic and contractile 
competence of the individual platelets present in the sample. 
The percent discharge of platelet lactate dehydrogenase (LDH) was 
determined in two steps by measurement of LDH activity by an automated 
analyzer (Hitachi 717, Boehringer-Mannheim; Indianapolis, IN). First, the 
LDH activity is measured in a 1 mL sample of PC where the platelets have 
been lysed with Triton X-100 detergent (isooctyl phenoxypoly- 
ethoxyethanol, Sigma Chemical Company; St. Louis, MO). This result is 
taken to be the total LDH activity present in a 1 mL sample of that unit 
of PC. At each sampling time, the LDH activity present in 1 mL of 
platelet-poor supernatant plasma (prepared by centrifugation at 15,000 rpm 
for 3 minutes in an Eppendorf 5414 centrifuge, Eppendorf Geratebau, GmBH; 
Hamburg, Germany) is measured. This result is taken to be the total 
extracellular LDH activity in 1 mL of that unit. Division of the 
extracellular supernatant level by the total LDH activity gives the 
percent of intracellular LDH released into the plasma at that time point. 
This has been shown to increase over time of storage and to increase when 
platelets are subjected to shear stress.As LDH is present in the 
platelet cytosol and not in granules, LDH discharge has been used as an 
indicator of platelet lysis but not the release reaction.^^ 
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The percent release of platelet J3-thromboglobulin (B-TG) was 
likewise determined in two steps. This protein is known to be contained 
CO 
in platelet a-granules and to be released during platelet activation. 
1 ?s • 
B-TG concentration was measured using a commercial I radioimmunoassay 
kit (Amersham Corp.; Arlington Heights, IL). Release of B-TG has also 
been shown to occur during processing and storage. 
Generation of complement fragments C3a and C5a was assayed using a 
commercial radioimmunoassay kit (Amersham Corp.). Some studies had 
suggested that UV-B radiation might quantitatively and/or qualitatively 
alter the expression of surface proteins (see Introduction). Such 
membrane effects could result in complement fixation with decreased in 
vivo survival either by opsonization of platelets or by the formation of 
transmembrane pores by the complement membrane attack complex (C5-C9). 
Samples were prepared for 2-dimensional polyacrylamide gel 
CQ 
electrophoresis (2D-PAGE) as described in detail by Snyder et al. 
Briefly, a 2.5 mL sample of PC is placed in a plastic tube containing 
buffer and chilled on ice to minimize platelet activation. Theophylline 
and EDTA are included in the buffer to stabilize membranes and reduce 
calcium fluxes, respectively. The sample is then centrifuged to remove 
erythrocytes. A buffer containing NaCl, glucose, adenosine, theophylline, 
phosphates, and two protease inhibitors, leupeptin and PMSF (phenyl- 
methylene sulfonyl fluoride), is added to the decanted platelet-rich 
plasma supernatant. The platelets are then sequentially washed and 
centrifuge-pelleted three times in ice cold buffer. While the final 
pellet contains mostly platelets, small numbers of erythrocytes (< 
1000/^L) and leukocytes (< 100//L/L) remain. The pellet is solubilized in 
9M urea with NP-40, ampholytes (pH 9-11), 2-mercaptoethanol and leupeptin. 
Samples are then stored frozen at -30®C and warmed to room temperature 
before beginning the 2D-PAGE procedure. 
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The 2D-PAGE analysis involves a first dimension isoelectric 
focusing in 1.5 x 20 mm acrylamide tube gels followed by a second 
dimension separation by molecular weight on acrylamide gradient slab gels. 
The method is described in detail by Anderson and Anderson,as modified 
from O'Farrell.Briefly, a 10-15 /jL sample of solubilized platelets 
containing 30-40 fjg of protein is loaded onto the top of an acrylamide 
tube gel and subjected to electrophoretic focusing in a pH gradient 
resulting in separation of proteins by isoelectric point. The tube gel is 
removed from the focusing apparatus and laid across the top of a 1.5 mm 
thick 9-18% gradient acrylamide slab gel. The combined tube-slab gel is 
now subjected to electrophoresis in a sodium dodecylsulfate (SDS) buffer 
resulting in separation of proteins by molecular weight. Commercially 
available equipment (Electro-Nucleonics Inc.; Oak Ridge, TN) allows for up 
to 20 first dimension tube and 10 second dimension slab gels to be run 
simultaneously. This batch processing reduces gel to gel variability and 
allows meaningful comparisons to be made between gels of different samples 
run at the same time under identical conditions.Following fixation in 
ethanol, acetic acid and sulfosalicylic acid, the slab gels are stained in 
batches with ammoniacal silver nitrate as described in detail in Guevera 
et al.^^ 
The 2D-PAGE system used, when combined with silver staining, has the 
power to display up to 10,000 individual protein spots and requires only 
about 1 ng of protein per spot to allow visualization.^^ Due to careful 
washing of the PC samples before electrophoresis, most of the major spots 
seen are platelet proteins and not contaminating plasma, leukocyte or 
erythrocyte proteins. To fully evaluate the complex gel patterns 
generated when whole solubilized platelets are electrophoresed, a computer 
image analysis system was used (Visage 2000, Bio Image; Ann Arbor, MI). 
This system allows detailed comparisons of spot number, density, size and 
position to be made between paired gels. The software has the flexibility 
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to allow for small differences in spot location between gels and, 
accounting for these discrepancies by digital mapping, to produce a spot 
by spot, quantitative comparison between the two gels. By scanning gels 
run on control and test samples from a single pool in the same 2D-PAGE and 
staining batches, a variety of comparisons were made, e.g. a non- 
irradiated control stored for 72 hours compared to its irradiated 
counterpart stored under identical conditions. Because the protein 
loading of gels was only approximately constant as judged by platelet 
counts and PC volumes, the full quantitative power of the computer system 
could not be applied. Therefore, the analysis of paired gels was confined 
to the qualitative accounting of spot numbers and relative intensity. 
For each of the quantitative in vitro assays, the mean ± 1 SD is 
reported. Statistical significance was taken to be p < 0.05 with paired 
t-tests used for comparisons. 
All manipulations and assays were performed by this investigator 
with the following exceptions: 
LDH by Clinical Chemistry at Yale-New Haven Hospital. 
B-TG, C3a, C5a, and morphology score by Ms. Paula Napychank, Medical 
Technologist, at Yale-New Haven Hospital. 
Computer gel scanning by Mr. Philippe Male of the Department of Cell 
Biology, Yale University School of Medicine. 
Part B: Storage of platelet concentrates following variable dose UV-B 
(600, 2400 or 10,000 mJ/cm^) irradiation 
Single donor platelet concentrates (SDP's) were prepared by 
apheresis collection from normal adult volunteer donors at Yale-New Haven 
Hospital (HIC Protocol #2000: Phlebotomy of Normal Volunteer Human Donors 
for Use in in vitro Studies) using a Fenwal CS-3000 Plus Blood Cell 
Separator with a separation chamber (TNX-6) and a collection chamber (A35) 
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(all by Baxter Healthcare Corp., Fenwal Division; Deerfield, IL) . 
Informed consent, according to HIC protocol, was obtained prior to the 
procedure and all donors were screened for viral disease markers before 
donation. For the total of 10 donor PC units used to prepare 5 two unit 
pools, 7 men and 2 women participated with one of the men contributing one 
unit to each of two different pools. 
The methods of automated blood processing available for the 
preparation of SDP's are discussed in detail by DePalma.^^ Briefly, an 
apheresis device such as the Fenwal CS-3000 automatically performs the 
continuous flow centrifugal separation of a stream of citrate-dextrose 
anticoagulated whole blood into component parts, e.g. platelet-rich 
plasma, plasma, leukocytes and erythrocytes, and returns to the donor 
those fractions that will not be collected. By using a closed, sterile, 
non-pyrogenic collection system (Fenwal Closed System Apheresis Kit for 
Extended Platelet Storage and Plasma Collection, Baxter Healthcare), the 
PC could be stored for up to 5 days at 20-24°C with gentle agitation, i.e. 
the maximum currently approved duration of storage for PC's. 
Approximately 2-4 x 10^^ platelets were collected at each donation, as 
determined by sterile sampling, in a plasma volume of about 400 ml. This 
single donor PC was stored overnight as two 200 mL aliquots, each in a IL 
PL-732 plastic bag (Baxter Healthcare) on a 70 cycle/minute linear 
platelet reciprocator (Melco Engineering Corp.; Glendale, CA) at 22°C in 
a temperature-controlled cabinet (Forma Scientific; Marietta, OH). 
The day following collection, the two ABO-identical SDP's were 
pooled and gently mixed in a single IL PL-269 bag (Baxter Healthcare). 
All transfers of PC between bags were carried out using a sterile 
connecting device (SCD 312; Haemonetics Corp.; Braintree, MA) , which 
allows for sterile welds to be made in connection tubing thereby not 
compromising the shelf-life of a closed system.For UV-B irradiation. 
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approximately 180 ml of PC were transferred to a 500 mL PL-269 bag. This 
corresponds roughly to the volumes irradiated in Part A. Three different 
doses (600, 2400 and 10,000 mJ/cm^) of UV-B radiation were used, 
administered by varying the time of exposure as judged by radiometer 
readings as described in Part A. The dose of 10,000 mJ/cm^ required 
approximately 20 minutes, 2400 mJ/cm^ approximately 5 minutes and 600 
mJ/cm^ about 1.5 minutes. The administration of the 10,000 mJ/cm^ dose 
required slightly more time in Part B than in Part A due to a decrease in 
the intensity of the bulbs over a 30 month period. Following irradiation, 
the PC’s were transferred back to standard IL PL-732 bags (Baxter 
Healthcare) for storage on the linear shaker (Melco Engineering) at 22°C. 
(See Figure 2 for flow diagram of PC handling) 
In addition to these three test units, two controls were used. For 
one of these, the heat control, a 130 mL volume of PC was placed in a IL 
PL-269 bag and incubated at 37°C in a temperature-controlled room for a 
p 
period of time corresponding to that required to complete the 10,000 mJ/cm 
irradiation. As discussed in Part A, irradiation at a dose of 10,000 
mJ/cm^ results in warming of a 4 unit volume of PC to approximately 30°C. 
Incubation of the heat control in this experiment at 37°C for 20 minutes 
resulted in similar endpoint temperatures as determined by thermometry. 
The heat control was then split into two 65 ml volumes, each stored in a 
300 mL PL-732 bag (Baxter Healthcare) at 22°C. The remaining 130 mL 
volume of PC was simply held in the IL PL-269 bag used for pooling for 20 
minutes at room temperature and then aliquoted for storage as two 65 mL 
volumes in 300 mL PL-732 bags. With these controls, the contribution of 
brief storage in PL-269 plastic and of warming to 30°C in PL-269 to any 
deleterious effects seen with the highest radiation dose can be examined. 
The control and test units were sampled immediately post-irradiation 
(0-4 hours) and at 24 and 96 hours post-irradiation as described in Part 
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A. White cell count, morphology score, osmotic recovery, tangent of 
osmotic recovery, LDH discharge and B-TG release were determined as in 
Part A. Platelet counts were run as 1:10 dilutions of PC in normal saline 
on a laser particle counter (Coulter Counter T660, Coulter Electronics; 
Hialeah, FL) . To evaluate the possibility of induction of metabolic 
derangements by UV-B irradiation, a number of metabolic parameters were 
examined — pH, PO2, PCO2, glucose, lactate, ATP, ADP, ammonia, glutamine, 
glutamate, and hypoxanthine. 
For determination of pH, PO2 and PCO2, a sample of PC was injected 
at 22°C into a standard blood gas analyzer (Nova Stat, Nova Biomedical; 
Waltham, MA) as soon as was practicable after withdrawal from the storage 
bag. However, due to clinical priorities, the delay was sometimes up to 
two hours, during which the PC sample remained in a capped syringe at room 
temperature. Samples for lactate, glucose, hypoxanthine, ammonia, 
glutamine and glutamate were centrifuged at 3,000 rpm for 15 minutes in a 
Sorvall GLC-4 centrifuge with H-IOOOB rotor (Ivan Sorvall, Inc.; Norwalk, 
CT) to yield a platelet, erythrocyte and leukocyte poor plasma 
supernatant. This was then capped and frozen at -30°C for up to 8 weeks 
for later analysis. Lactate concentration was determined by an automated 
analyzer (TDX Analyzer, Abbott Diagnostics; Irving, TX) , as was glucose 
(Astra-8, Beckman Instruments; Brea, CA). Hypoxanthine was measured by an 
enzymatic method relying on a change in absorbance at 280 nm as 
hypoxanthine is converted to uric acid by xanthine oxidase.L-glutamine 
and L-glutamate were measured by an enzymatic method using glutaminase to 
convert L-glutamine to L-glutamate followed by oxidative deamination of L- 
glutamate to 2-oxoglutarate by glutamate dehydrogenase with the resultant 
increase in NADH concentration being monitored by absorbance change at 339 
nm.^^ Ammonia was measured using a commercial enzyme kit based on the 
glutamate dehydrogenase reductive amination of 2-oxoglutarate with 
consumption of NADH monitored by absorbance change at 339 nm (Sigma 
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Chemical Company; St. Louis, MO). Samples for total ATP and ADP analysis 
were prepared by ethanol-EDTA solubilization of PC followed by 
centrifugation at 15,000 rpm for 1 minute in an Eppendorf 5414 centrifuge 
(Eppendorf Geratebau, GmbH; Hamburg, Germany). The resultant supernatant 
was capped and frozen at -70°C for later analysis. ATP concentration was 
determined using a modified firefly luciferin/luciferase assay^ with ADP 
concentration being calculated as the difference between ATP concentration 
as measured following addition of creatine phosphokinase and 
phosphocreatine to the system and that measured without such addition. 
Samples for hypoxanthine, L-glutamine, L-glutamate, ammonia, ADP and ATP 
were shipped overnight on dry ice to an outside lab (see below). 
For each of the above in vitro assays, the mean ± 1 SD is reported. 
Statistical significance as taken to be p < 0.05 with a repeated measures 
analysis of variance used for comparisons (SAS/STAT, Release 6.04, SAS 
Institute, Inc.; Cary, NC) run on an IBM PS/2 Model 80. 
All manipulations and assays were performed by this investigator 
with the following exceptions: 
Collection of PC’s by Pheresis Service at Yale-New Haven Hospital. 
LDH and glucose by Clinical Chemistry at Yale-New Haven Hospital. 
/3-TG and morphology score by Ms. Paula Napychank, Medical 
Technologist at Yale-New Haven Hospital. 
Blood gas analysis by Operating Room Staff at Y-NHH. 
ATP, ADP, ammonia, hypoxanthine, glutamine and glutamate by Scott 
Murphy, M.D. and his laboratory staff at the Cardeza Foundation 
for Hematologic Research of Jefferson Medical College, Thomas 
Jefferson University, Philadelphia, PA. 
Statistical analysis by Ms. Karol Katz at the Biostatistics 
Consulting Unit, Yale University School of Medicine. 
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RESULTS 
Part A; Storage of platelet concentrates after hiah-dose ultraviolet-B 
irradiation 
The numerical results of the in vitro assays performed in this 
series of experiments are seen in Table 1. 
No statistically significant changes were seen in any of the 
parameters studied over the first 24 hours of storage following UV-B 
irradiation. In addition, no significant changes were noted in pH, 
platelet count, or white cell count over 96 hours of post-irradiation 
storage when the control (non-irradiated) and test (UV-B) groups were 
compared (n=6, p>0.05, NS). The control and test groups also did not 
exhibit differences at 96 hours in the discharge of LDH, release of B-TG 
or formation of complement fragments C3a and C5a (n=6, p>0.05, NS). By 96 
hours of storage, however, the generation of C3a, LDH and B-TG had 
increased significantly for both groups (p<0.05). After 96 hours of 
storage, significantly lower morphology scores, osmotic recoveries and 
tangents of osmotic recovery were measured in the UV-B treated group as 
compared with the non-irradiated controls (p<0.05). Of the irradiated 
platelets evaluated at 96 hours, 50% showed a morphology score close to 
the lowest value (200) and an osmotic recovery of zero. 
The 2-D PAGE pattern of paired irradiated and non-irradiated PC's 
stored for 72 hours is shown in Figure 3. 
The computer program used to analyze the paired gels identified 745 
discrete protein spots on each gel. The majority of these were 
essentially identical in location and intensity. The computer did find, 
however, 71 spots that differed when the test and control gels were 
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compared. Of these, 43 were present on the gel of the UV-B treated PC and 
were absent on the gel of the paired control PC; 19 spots were present on 
the control but not on the test gel; and 9 spots were found on both gels 
but differed markedly in intensity: 8 were darker on the test gel and 1 
was darker on the control gel. The majority of the protein spots 
generated by the 2-D PAGE system have not been identified. It is, 
therefore, unclear whether the changes noted occurred in cytosolic, 
mitochondrial, granular, cytoskeletal or surface membrane proteins. 
Snyder ^ provide an idealized computer-generated map of the protein 
pattern obtained when solubilized, whole human platelets are subjected to 
2-D PAGE. 
Part B; Storage of platelet concentrates after variable-dose 
ultraviolet-B irradiation 
The numerical results of the in vitro assays performed in this 
series of experiments are seen in Tables 2 and 3. 
The computer statistical software package used provided several 
analyses. The 96 hours of post-irradiation storage encompassed 3 sampling 
times (0-2, 24 and 96 hours post-irradiation). A repeated measures 
analysis of variance using univariate tests of hypotheses for within 
subject effects was used to determine whether the test (irradiated) and 
control (non-irradiated) groups differed in a given assay over all 3 
sampling times. This is equivalent to plotting the mean values for a 
given assay at the 3 sampling times for the control and test groups on a 
linear scale and comparing the slopes of the resulting 2 curves. For 
comparisons between control and test groups in a given assay at each 
sampling time point, a repeated measures analysis of variance (pairwise 
comparisons) using a general linear models procedure with least squares 
means was employed. This is equivalent to plotting the mean values for a 
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given assay for the control and test groups on a linear scale and 
comparing the two groups only at each time point in isolation without 
reference to trends over time. The effect of time of storage was 
evaluated by a repeated measures analysis of variance using univariate 
tests of hypotheses for within subject effects. 
The following comparisons between groups were made using the above 
procedures; room temperature control with heat control; room temperature 
control with each of the three UV-B doses (600, 2400 and 10,000 mJ/cm^); 
heat control with 10,000 mJ/cm^; 600 mJ/cm^ with 2400 and 10,000 mJ/cm^; 
and 2400 with 10,000 mJ/cm^. Reference will be made to differences that 
are seen between groups in comparisons over the full 96 hour storage 
period and in comparisons at the individual 0-2, 24 and 96 hour sampling 
points. 
Over 96 hours of storage several assays did reveal statistically 
significant (n=5; p<0.05) differences between the irradiated and non- 
irradiated units. Importantly, when the non-irradiated room temperature 
and non-irradiated heat controls were compared, none of these differences 
was seen. This speaks strongly against a thermal effect of UV-B 
irradiation. 
For pH, while all irradiated and non-irradiated groups showed a 
significant decline in pH over 96 hours of storage, a signficant decrease 
in the 10,000 mJ/cm group was seen when the room temperature control, heat 
control, 600 mJ/cm^ and 2400 mJ/cm^ were compared to the 10,000 mJ/cm^ 
group. This effect was apparent by 24 hours of post-irradiation storage 
and marked by 96 hours of storage. No such decrement in pH was noted for 
the comparisons of room temperature control with 600 mJ/cm^, room 
temperature control with 2400 mJ/cm^ and 600 mJ/cm^ with 2400 mJ/cm^. This 
suggests that lower doses of UV-B radiation and 37°C incubation are 
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insufficient to cause a significant fall in pH, as the effect is observed 
only following the highest UV-B dose. 
Measurements of PCO2, PO2, platelet count and white cell count 
revealed no significant differences between irradiated and non-irradiated 
units. Over 96 hours of storage, all groups showed statistically 
significant decreases in PCO2 and platelet count; PO2 was stable in all 
groups during storage. 
Morphology scores were significantly lower in the 10,000 mJ/cm group 
over 96 hours of storage only for the comparison of 2400 versus 10,000 
mJ/cm^. In addition, the comparisons of room temperature control with 
10,000 mJ/cm^ and heat control with 10,000 mJ/cm^ revealed significantly 
lower scores in the irradiated group at 96 hours of storage. This effect 
was not apparent at 24 hours of storage. All groups showed a drop in 
morphology score over 96 hours of storage. 
The osmotic recovery assay failed to reveal any differences between 
the control (room temperature and heat) and irradiated units over the full 
period of storage. However, at 96 hours of storage, significantly lower 
osmotic recoveries were noted for the irradiated group in the comparison 
room temperature control versus 10,000 mJ/cm^. 
Tangent of osmotic recovery, discharge of LDH and release of B-TG 
showed no significant differences between control (room temperature and 
heat) and irradiated units over 96 hours of storage or at any of the 3 
time points of storage. All groups showed significant increases in 
generation of LDH and B-TG over 96 hours of storage. 
Measurement of supernatant glucose concentration revealed a 
consistent effect of the 10,000 mJ/cm^ dose over the 96 hour storage 
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period. Comparisons of the room temperature and heat controls with this 
high dose of UV-B and of the lower doses (600 and 2400 mJ/cvc?) with 10,000 
mJ/cm^ all demonstrated significantly lower glucose levels in the 10,000 
mJ/cm^ irradiated units. This was not seen when the room temperature 
control was compared to either the 600 or the 2400 mJ/cm^ dose. The 
decline in glucose concentration was most apparent at 96 hours post¬ 
irradiation. As all units started with equal platelet counts in identical 
suspending fluids and were stored and handled similarly, the fall in 
supernatant glucose concentration that was noted in the 10,000 mJ/cm*^ group 
can most likely be attributed to increased metabolism by the platelets 
present in those PC's. The possibility of gross bacterial contamination 
resulting in consumption of glucose can be ruled out as all PC units were 
examined microscopically (wet mounts) as part of the morphology scoring 
procedure. All groups showed a significant temporal decline in glucose 
concentration over the 96 hours of storage. 
Measurement of supernatant lactate concentration yielded results 
consistent with those found with glucose. Comparisons of the room 
temperature and heat controls with the 10,000 mJ/cm^ dose and of the lower 
doses (600 and 2400 mJ/cm^) with 10,000 mJ/cm^ all demonstrated 
significantly higher lactate levels in the 10,000 mJ/cm^ irradiated units 
over 96 hours of storage. In contrast to the results with glucose, 
p 
however, this augmented lactate production also occurred in the 2400 mJ/cm 
group when it was compared to the room temperature control and the 600 
mJ/cm group over 96 hours. Moreover, the rise in lactate levels in the 
p 
10,000 mJ/cm‘^ group, as compared to the room temperature control or either 
of the 2 lower doses of UV-B, achieved significance by 24 hours of post¬ 
irradiation storage and persisted at 96 hours. Employing the same 
reasoning as applied to the glucose results, the higher supernatant levels 
of lactate can most likely be attributed to greater metabolic generation 
by the platelets in the 2400 and 10,000 mJ/cm^ groups. All units showed 
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a significant increase in lactate levels over the 96 hours of storage. 
Ammonia, glutamine, glutamate, ADP and ATP assays showed no 
significant differences between the control and irradiated groups over the 
full storage period or at any point of storage. All groups had 
significantly higher ammonia and glutamate concentrations after 96 hours 
of storage. Glutamine, ADP and ATP levels were noted to be significantly 
lower in all groups after 96 hours of storage. 
Due to technical problems with the hypoxanthine assay in Dr. 
Murphy's laboratory, several data points were not obtained. Because of 
this, the data were not subjected to statistical analysis and firm 
conclusions cannot, therefore, be drawn from the available data. It would 
appear from inspection of the results, however, that a temporal effect of 
storage can be seen as all groups have markedly higher hypoxanthine levels 
at 96 hours than at 0-2 hours. 
In summary, the investigations of Parts A and B of the study 
revealed that UV-B radiation has several potentially important effects on 
stored platelet concentrates. In Part A, significantly lower morphology 
scores, osmotic recoveries and tangents of osmotic recovery were noted 
after 96 hours of post-treatment storage in the irradiated (10,000 mJ/cm^) 
group of PC's as compared to the non-irradiated control group. Computer 
analysis of 2-D PAGE patterns revealed changes in over 70 protein spots 
after 72 hours of post-irradiation storage. Of these, 43 spots were 
present on the gels of irradiated PC's that were absent from gels of non- 
irradiated controls. 
In Part B, the effects of a 10,000 mJ/cm^ UV-B dose on osmotic 
recovery and morphology score were confirmed. Again, significant 
decrements in these 2 parameters were noted in the 10,000 mJ/cm^ group at 
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96 hours of storage when compared to control groups. Assays for glucose 
and lactate revealed significantly augmented glucose metabolism in the 
10,000 mJ/cm^ group by 96 hours and significantly enhanced lactate 
generation in the 2400 and 10,000 mJ/cm^ groups by 24 hours and continuing 
up to 96 hours. Commensurate with these metabolic changes, measurement of 
pH showed a significantly greater drop in 10,000 mJ/cm^ group, as compared 
to the control groups, by 96 hours of post-treatment storage. Levels of 
other key platelet intermediary metabolites, including ammonia, glutamine, 
glutamate, ADP and ATP, did not indicate a specific effect of UV-B 
radiation. 
DISCUSSION 
The results of the assays performed in Parts A and B of this 
investigation provide a view of the effects of graded doses of UV-B 
radiation on the in vitro storage characteristics of PC’s. While only a 
few of the parameters studied showed statistically significant changes in 
the irradiated units as compared to non-irradiated controls, the assays 
that did reveal changes may indicate potentially serious adverse effects 
of UV-B radiation on stored PC's. Importantly, the results of Part B 
appear to exclude heating during irradiation as a factor in inducing these 
alterations. 
In Parts A and B, significantly lower morphology scores, osmotic 
recoveries and tangents of osmotic recovery (Part A only) were noted at 96 
hours of storage following a 10,000 mJ/cm^ dose of UV-B energy. One study 
has demonstrated a positive correlation between morphology score and in 
vivo survival of transfused platelets as measured by ^^Cr labelling 
studies.Scores below 400 were consistently associated with a 
significantly reduced post-transfusion circulating half-time. At 96 hours 
f»_' »»' ti^f^.V4MI'it'^lli^:.;.'A 
' *1 •' •' * s’ . ■■ 
.;• h--‘ . * 
, -SJ. •• ’ -.s;,' •• . 
■ ■ ■-■■■^ ' 
y. >*’■ 
I u . 1 
»i'.'' 1 
r • .,\ ¥>' ^ >« .i^r 000,ui 
>/ ''' . t ■' <4 **’ 
■.itir, > •"•y i' :■■ ■ '.■ -V".' ' "• <? > (U 
< ' .• . ’ »' ji T • •* ‘> - ‘.'l 
. ’ ■k';, .1. i.;«-D «4.y f 
. ' 3-i ■ -''^t •)!--»* Mi ■, .; •» 
. :.V'.. . ^ ^ w ; 
-, -4: ‘ 
• •:■ ''Ic j* -tp'-a - V * . ^ •> , • - ,vt ^ (n I-* *1 ii 
-- .'• “•^.,•“.1 fi;* t ,.JnaA x« V' «'.»'■»:? j— . t' *ji "tp*!’- ' t ■ 
''•.3 t''*'■ ' ’ ^ '* * *•' ■ yi'* ^ * -\ ' % Vo 
.■•'<». » tco« i:. » IIP., y r':»J I V ' •rt, 4t,VO0*h #•# ‘'' ' 
• tM'k ftS^ it* ') " 4 . 1 ;i>ytY.i8*- c*U ,.^ 
ft 4^,i*¥ ►. ■/J ■'^/r*;A4.-.«. .# 7 ■ ■ •.1*# - ' 'iJ 
V. 
•iMUfl Of 4«* .»^(' --if ,•■ .'xH\ r' pu»»f'■ '■ ■! ' r. i.,;. ♦ «. 
i' ' 
-32- 
post-irradiation, 50% of the treated units in Part A showed a morphology 
score close to 200, i.e. the lowest possible score. 
The osmotic recovery phenomenon has been interpreted to reflect 
initial platelet swelling in the hypotonic medium due to free water influx 
followed by extrusion of this water with contraction by the platelets. 
It has been demonstrated that the process of osmotic recovery requires 
both intact contractile proteins^^ and competent metabolic pathways.^ 
Studies using inhibitors of energy metabolism, specifically glycolytic 
blocking agents, suggested that osmotic recovery is an energy dependent 
process.In addition, the percent of osmotic recovery has been shown to 
correlate positively with in vivo survival as measured by ^^Cr studies. 
In Part A, fully 50% of the 10,000 mJ/cm^ irradiated units had an osmotic 
recovery of zero at 96 hours and the mean osmotic recovery for the 
irradiated units at that time following treatment was only 17%. These 
PC's would be expected to have less than optimal survival characteristics 
following transfusion. The significantly lower tangents of osmotic 
recovery seen in the irradiated units at 96 hours in Part A are further 
evidence for the derangement of metabolic and/or contractile systems by 
UV-B radiation. However, as demonstrated in Part B, only the 10,000 mJ/cm^ 
irradiated units appeared to suffer a significant decrement in osmotic 
recovery and then only after 96 hours of post-irradiation storage. The 
results of the measurements of key intermediary metabolites in Part B, 
specifically glucose and lactate, are consistent with the likelihood that 
a metabolic disturbance is responsible for the decreases in osmotic 
recovery seen with high doses of UV-B radiation. 
A number of investigators have sought to elucidate the pathways of 
platelet intermediary metabolism.^®*^® It has become clear that plasma 
glucose is an important substrate for energy metabolism, contributing 
approximately 15% of ATP requirements during normal aerobic storage 
■ 
1 !, ■'*<«>*| ‘ *l» . * . , ,-■■ -i-it '■t«% .'.! * <►♦*'■>*(11 
. 1 .VI, ■■ 
1 . ^ |j,l.-—<.111 . 1 M y- ' ? K ; 4s» f 
r^'S »** f.' Me-; 
■ i» •« f ' ti', ft 
■ '»■ ' ^3 C 
♦ i t.1,', > • ■ tt ,! «• #1)4 #1 •/ / i 
s 
* ' itt 'tf li'i 
* ‘ 
r 
• ,- f Zf ^ 
1 ;. 1 ■ i . f , 1 , . _i '.-'I ■ 
.* ' -—T «.( 
r- 'J i ■ 
*» J! '■|■■! '* S': aM» ‘ - V : *1 
'•■ it ' - f'. 
, , , .»_**> ’ M ^ ' Vj 
< 
*>* m-Jn/iu r* X' A'» »1 
V 
! ; • .  i-1 < ■* •T ‘1W»> 
i 1 . ",4 \ ' • -.1 ■ ' ■ ' ■• «.r . IW£*-* 
. ’ ‘W 
; . ’ "(I" v^ • ■*'■’ •»« .•■/<?* ' - ‘rv' 
• • ■ • j ♦ • 1. V n - '• . ■“^'' 
*•■ » . • .1 ">' ■ ■ -^' ■ > 
V*: 1 =■•'- j m ©i' 
>'.ai(rH ""-'A 
-33- 
largely via glycolytic catabolism to lactate. Oxidative 
phosphorylation, perhaps utilizing plasma free fatty acids via B- 
oxidation,^^ contributes the remaining The importance of O2 and 
CO2 exchange across the storage plastic has been elegantly examined by 
Murphy and Gardner.The existence of the Pasteur effect has also been 
demonstrated in stored platelets. This refers to the phenomenon of 
increased lactate production under anaerobic conditions as the platelet 
attempts to compensate for the loss of oxidative phosphorylation as an 
energy source by increasing glycolytic activityThe potential 
for high (>20 mmol/L) lactate concentrations to exceed plasma bicarbonate 
buffering capacity and, thereby, result in a damaging fall in pH has been 
documented. 
The greater glucose consumption and lactate production seen in the 
irradiated units in Part B suggests that UV-B treatment, particularly the 
higher doses of 2400 and 10,000 mJ/cm^, resulted in accelerated glycolytic 
metabolism. For example, the 10,000 mJ/cm^ group consumed, by 96 hours an 
average of 5.7 mmol/L of glucose per unit and produced an average of 11.1 
mmol/L of lactate per unit. (See Table 2) The ratio of lactate produced 
to glucose consumed is, therefore, approximately 1.95. This is close to 
the stoichiometry expected for glycolytic metabolism of glucose, i.e. 2 
moles of lactate produced for each mole of glucose consumed. The room 
temperature control group consumed, by 96 hours, an average of 4.0 mmol/L 
of glucose per unit and produced an average of 6.6 mmol/L of lactate per 
unit (See Table 2). Here, the ratio of lactate produced to glucose 
consumed is 1.65. It would appear that in the control group, more glucose 
was consumed that can be accounted for by glycolytic production of 
lactate. This is not readily explained but may represent oxidative 
metabolism of glucose. In the 10,000 mJ/cm^ group, almost all of the 
glucose consumed appeared as lactate. This reasoning holds if all lactate 
production is assumed to be a result of glycolysis.Interestly, the 
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ratios of lactate produced to glucose consumed for the heat control, 600 
and 2400 mJ/cm^ groups are 1.77, 1.72 and 1.86, respectively. The glucose 
and lactate values for the heat control and the 600 mJ/cm^ radiation group 
were not statistically significantly different from the non-heated control 
values. Since the values for the 2400 mJ/cm^ and the 10,000 mJ/cm^ groups 
were different, this suggests a progressively greater shift to the 
glycolytic metabolism of glucose only with higher doses of UV-B radiation. 
Pamphilon also noted increased glucose consumption and lactate 
production in PC units irradiated at 300 mJ/cm and subsequently stored for 
up to five days. 
A significant decline in pH was also noted in the 10,000 mJ/cm^ group 
in Part B. Studies have shown both decreased in vivo survival of 
transfused platelets and a fall in morphology score when pH falls below 
6.4 or rises about 7.4 during storage.The more rapid decline in pH 
in the high-dose UV-B irradiated units can likely be attributed to the 
additional lactic acid produced by these PC's. However, the average pH at 
96 hours in the 10,000 mJ/cm^ group was 7.05, well within the range of 
acceptable. This suggests that the excess lactic acid did not exceed the 
available plasma bicarbonate buffering capacity. This is in agreement 
with the finding that only lactate concentrations above 20 mmol/L result 
in deleterious falls in pH.^*^ The mean lactate concentration at 96 hours 
in the 10,000 mJ/cm^ group was 15.0 mmol/L. 
If, in fact, the changes in glucose metabolism can be attributed to 
an acceleration in glycolysis, the reason(s) for this acceleration must be 
sought. Broadly, potential explanations can be divided into two 
categories. First, the augmented glycolytic rate may be a reflection of 
additional energy requirements in irradiated platelets, i.e. the energy 
derived from the glycolytic pathway was required to supply greater than 
normal energy needs. In this case, glycolysis was recruited to provide 
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energy beyond that produced by oxidative phosphorylation. Second, the 
accelerated glycolytic rate in the irradiated PC's may indicate a failure 
of other energy sources, i.e. the energy derived from the glycolytic 
pathway is compensation for a failure of oxidative metabolism. 
Unfortunately, assays other than glucose and lactate that might have been 
expected to reveal effects of UV-B radiation on energy metabolism did not 
do so. This makes it difficult to distinguish between the two 
possibilities. It is possible, however, to suggest some plausible 
explanations. 
Measurements of PCO2 and PO2, a by-product of and a substrate for, 
respectively, oxidative phosphorylation, failed to demonstrate a UV-B 
specific effect. As detailed in Murphy and Gardner,the plasma PCO2 and 
PO2 reflect the aggregate oxidative metabolism of the PC, i.e. the 
inhibition of mitochondrial activity would be reflected as PCO2 and PO2 
near atmospheric levels while accelerated oxidative phosphorylation would 
yield a higher PCO2 and a lower p02. Neither of these phenomena was seen 
as an effect of UV-B irradiation as the results of PCO2 and PO2 were 
similar in both treated and control groups. However, the delay between 
sampling and measurement was occasionally up to 2 hours and this may have 
reduced the sensitivity of the assay for small differences in ©2 
consumption and CO2 production. Ideally, blood gas measurements should be 
made immediately (less than one minute) following sampling to minimize 
changes in PCO2 and PO2 caused by ongoing platelet metabolism in a closed 
system (syringes allow for little, if any, gas exchange) 
Assays for total platelet ADP and ATP also failed to demonstrate any 
consistent effect of UV-B radiation. Both non-irradiated and irradiated 
groups had similar ADP and ATP content over the storage period. Also, 
assays for hypoxanthine and ammonia, products of adenosine catabolism, 
gave similar results for treated and untreated PC's. This again suggests 
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that overall platelet production and utilization of ATP was not 
significantly affected by UV-B exposure. An effect of UV-B radiation on 
energy metabolism cannot be excluded, however, as studies using the 
specific respiratory inhibitor antimycin A have shown that platelets can 
maintain a constant energy charge (total intracellular ATP) even in the 
face of a near complete blockade of oxidative phosphorylation. The 
source of ATP in this case is glycolysis and an acceleration of activity 
in this pathway is reflected as increased glucose uptake and lactate 
product ion. This is an example of the Pasteur effect of enhanced 
anaerobic metabolism in compensation for reduced aerobic metabolism.^'^'^*^ 
Recall that the irradiated PC's, particularly those exposed to higher 
doses of UV-B energy, showed a consistent and dose-related augmentation in 
glycolytic rate as shown by glucose and lactate levels. Based on these 
data, the rise in glycolytic activity in irradiated units may reflect 
inhibition of oxidative metabolism by UV-B radiation. 
The other possibility, that increased glycolysis was required due to 
greater than normal energy requirements, is difficult to evaluate. The 
complex pathways of platelet activation, shape change and granule 
discharge are known to require energy.^ But, to judge from release of B- 
thromboglobulin, a marker of platelet activation,^® UV-B treatment did not 
induce significant activation. Other causes of increased energy 
requirements might include activation of proteolytic pathways, stimulation 
of mitochondrial DNA repair and transcription, and, generally, 
acceleration of any energy-dependent enzyme system. However, no assays 
relevant to these possibilities were evaluated in either Parts A or B. In 
addition, it is possible that the acceleration in glycolysis reflected 
both increased energy requirements and a failure of oxidative metabolism. 
As the total ADP and ATP concentrations were unaffected by UV-B treatment, 
no conclusions can be drawn about total energy needs with the evidence at 
hand. It also must be remembered that glucose, via glycolysis, supplies 
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only about 15% of the ATP needed by platelets during storage; the 
remaining 85% comes from oxidative metabolism utilizing free fatty 
acids.Definitive metabolic evaluation would require that assays of 
fatty acids and radiolabelling studies of substrate handling be included 
in the battery of in vitro assays. 
UV-B radiation was shown in Part A, at a dose of 10,000 mJ/cm^, to 
induce significant decreases in morphology score, osmotic recovery and 
tangent of osmotic recovery at 96 hours of storage following irradiation. 
These results were generally confirmed in Part B. Both morphology score 
and osmotic recovery have been shown to correlate positively with in vivo 
survival.A metabolic disturbance was suggested by the results of Part 
B. Specifically, an acceleration in glycolytic activity with maintenance 
of a constant ATP and ADP pool was found when irradiated and non- 
irradiated units were compared. A derangement in energy production or 
utilization is consistent with the finding of decreased osmotic recovery, 
a process known to be energy-dependent.^ Recall that the increase in 
glycolytic activity may reflect compensation for a failure of oxidative 
metabolism or the recruitment of an additional pathway to supply greater 
than normal energy needs or a combination of both. Accordingly, the 
results of Parts A and B do not allow differentiation between these two 
possibilities. 
As mentioned in the Introduction, the mechanism(s) by which UV-B 
radiation reduces the HLA immunizing potential of antigen-presenting cells 
has yet to be definitively identified. Alterations in protein expression 
and synthesis, e.g. ICAM-1 and interleukins, have received particular 
attention. The results of the 2-D PAGE studies in Part A suggest that 
platelet proteins themselves may be direct targets of UV-B radiation. 
The 2-D gel pattern of a PC treated with UV-B radiation of dose of 
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10,000 mJ/ctn^ and stored for 72 hours showed changes in over 70 proteins 
as compared to an age-matched non-irradiated control. Of the 71 proteins 
with changes, 43 were present on the test gel that were not present on the 
control. It is possible to speculate that some of these 43 spots may 
represent proteolytic fragments induced by UV-B treatment. This could be 
an important effect of UV-B radiation as platelets do not have the ability 
to synthesize proteins in significant amounts. Indeed, platelet 
mitochondria are the only source of new platelet proteins.Resolution 
of this question would require identification of at least some of the 
protein spots involved. This would necessitate isolation of these 
proteins in amounts sufficient to allow amino acid sequencing. At this 
time, it is unknown whether the proteins affected by UV-B treatment are 
membrane, cytosolic, mitochondrial, granular or cytoskeletal in origin. 
The possibility that the expression of important surface membrane 
proteins is altered by UV-B irradiation was suggested by work done in a 
collaborating laboratory during Part A. (Teresa C. Wooten, 1992 Yale 
medical student thesis, "Storage of platelet concentrates after 
ultraviolet B irradiation: The effects on membrane glycoproteins GP 
Ilb/IIIa and GP Ib.") These investigators found a significant decline in 
the platelet surface expression of GPIb, a glycoprotein essential to 
platelet adhesion, at 96 hours of storage following irradiation. Using 
flow cytometry and fluorescent monoclonal antibody labelling, a 60% 
reduction in surface GPIb was seen at 96 hours. Expression of a 
glycoprotein important in platelet aggregation, GP Ilb/IIIa, was not 
affected by UV-B treatment and storage. The decrement in GP Ib expression 
could adversely affect iji vivo function of the transfused platelets. 
Previous studies of the effects of UV radiation on whole cells and 
organelles have suggested several mechanisms through which UV light can 
have deleterious effects. Two of these may be particularly relevant to 
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the issue of UV-B irradiation of PC's; mitochondrial damage^^'®^ and 
disruption of microtubules.®^ A study using far ultraviolet light, which 
includes UV-B, demonstrated rapid swelling and subsequent lysis of 
mitochondria in response to UV exposure.®® It is currently unclear why 
lysis follows exposure but numerous explanations have been offered based 
on known actions of UV energy in other systems. These include induction 
of DNA-to-protein crosslinks, single strand DNA breaks, DNA intrastrand 
7Q 81 -85 
crosslinks and free radical generation with induction of proteolysis. ' 
If the enhanced rates of glycolysis noted in Part B occurred in 
compensation for an inhibition of oxidative phosphorylation, UV-induced 
mitochondrial damage is an attractive explanation. An important study to 
resolve this question might involve, in addition to more detailed 
metabolic assays, ultrastructural examination of platelet mitochondria 
with electron microscopy. 
The potential importance of a disruption of microtubule function is 
reflected in the possible role of microtubules in the osmotic recovery 
phenomenon.®^ It is reasonable to assume that microtubules may be involved 
in other shape changing processes of platelets, e.g. activation. The 
decreases in osmotic recovery and morphology score seen following high- 
dose UV-B treatment and storage may reflect inhibition of microtubule 
function in addition to, or instead of, disturbances in energy metabolism. 
Only more elaborate studies of platelet microtubules could resolve this 
issue. 
In summary, the observed effects of UV-B radiation on stored PC's, 
namely decreases in osmotic recovery, tangent, morphology score and pH 
with enhanced glycolytic activity and alterations in 2-D PAGE pattern may 
reflect one or more loci of action. Mitochondrial damage, disruption of 
microtubules, enhanced proteolysis and changes in surface membrane 
proteins are all possibilities. However, the results of this 
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investigation do not allow definitive conclusions to be made regarding 
these more general issues. The results do support the conclusion that UV- 
B irradiation of PC's at a dose of 10,000 mJ/cm^ with subsequent 96 hour 
storage is likely to result in functional and metabolic derangements. 
Lower doses of UV-B radiation and/or storage for shorter periods is less 
likely to induce significant functional and metabolic changes. 
Elucidation of the exact nature of the metabolic and functional 
changes found in this study will require detailed examination of platelet 
energy metabolism and identification of the proteins that are affected by 
UV-B radiation. The significance of the iji vitro findings will also need 
to be evaluated by in vivo transfusion studies including survival, 
recovery and hemostatic efficacy assays. Preliminary in vivo studies 
involving UV-B treated PC's have been reported.The incidence of HLA 
alloimmunization does appear to be reduced when UV-B irradiated PC's are 
used and radiolabel survival, recovery and bleeding time data suggest 
adequate platelet function following transfusion. The present work points 
to the importance of further defining the mechanisms whereby UV-B 
radiation may damage platelets. Furthermore, there is a need to find the 
optimal UV-B dose that will reliably reduce the incidence of HLA 
alloimmunization and, simultaneously, allow treated PC's to be stored with 
minimal deterioration over their full shelf-life. 
A • ,>i r ■.««•'. .4, K " '-, (. . -v-r!;'.^ 
\t, 'kiv,' ^..‘*.• m >• A-’b'i j *. j, .. **'■,, i 
; f V '. .■ >•» - \liH-i 1 X'.* ' 
.,fu ,:... »c\ .■‘'f • • •. t J s V*) ^ V 
. ff.uv. • • > . .t • il » ' ^tif I"li t ; i . tjl • C 
■ ■■ ^ 
'-M 
■' 
i ■* *■' 1 ‘ .■ 
*- ■ mu C-t 
<* nil ^ if* 0-»-I 
........ ..:.-.J 
’ - i ^ J^BF • ■•/■.>» I"!*-' y.J 
nv' * ;»<#«Ctk t 
J¥%' 
^ ■ '■' "'V 
* •■Ik' ,j <».i . iJBhiii 
^ . if*' 
'jtw mmni -^■'*- ^'ly 
« mi >*".. *.. 
ir.t . ♦. - • vJltf ’ « iflW . V <'»( 
r 
» 
? 
J 
4 
-41- 
ABO-identical 
RDP’s (PL-732) 
pooled 
and aliquotted (PL-732) 
irradiated (PL-269) 
returned to PL-732 
and stored 
Figure 1: Flow diagram for handling of platelet concentrates in Part A. 
See text for explanation. ”C" and "T" above correspond to control and 
irradiated test units, respectively. 
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ABO-identical 
SDP's (PL-732) 
pooled 
and aliquotted (PL-269) 
irradiated, heat treated 
or held (PL-269) 
returned to PL-732 
and stored 
Figure 2: Flow diagram for handling of platelet concentrates in Part B. 
See text for explanation. Numbers above correspond to experimental 
conditions: 1: room temperature control; 2; 37°C control; 3: 600 mJ/cm^ UV- 
B; 4: 2400 mJ/cm^ UV-B; 5: 10,000 mJ/cm^ UV-B. 
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A B 
ACIDIC -- pi-► BASIC ACIDIC -- pi -- BASIC 
Figure 3: Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
pattern (silver stain) of paired samples of PC obtained from a single 
pool: A) control {non-irradiated) stored for 72 hours; B) irradiated at 
10,000 mJ/cm^ and stored for 72 hours. The isoelectric focusing axis 
(abscissa) places acidic proteins to the left and basic proteins to the 
right. The molecular weight axis (ordinate) places higher weight proteins 
at the top and lower weight proteins at the bottom. For reference, the 
molecular weight of actin is 43,000 Daltons. Although protein loading was 
only approximately equal, several easily visualized spots (see marked 
examples) appear to show a significant change in intensity. 
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